Study of the Vaginal Microbiota in Women Under Fertile Age
vaginalbiota
Characterization of the Vaginal Microbiota in Fertile Age: Correlations Clinical and Pathogenetic Correlations Among Gynecological Disorders.
1 other identifier
observational
120
1 country
1
Brief Summary
Characterization of the vaginal microbiota of women under fertile age and study of correlations with gynecological disorders
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedFirst Submitted
Initial submission to the registry
March 21, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedApril 18, 2023
April 1, 2023
4 months
March 21, 2023
April 4, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Microbiota
Change from baseline in the composition of the vaginal microbiota with the increase of the cell density of lactobacilli (at least 3 log units) and decrease of pathogens (at least 2 log units) at the end of the treatment (10 days) and during the wash-out period (4 weeks after the end of the treatment)
Baseline; end of the treatment (10 days) ; wash-out (4 weeks)
Signs
Change from baseline of Amsel's criteria at the end of the treatment (10 days) and during the wash-out period (4 weeks after the end of the treatment)
Baseline; end of the treatment (10 days) ; wash-out (4 weeks)
Signs
Change from baseline of the Nugent score with values between 0 and 3 at the end of the treatment (10 days) and during the wash-out period (4 weeks after the end of the treatment)
Baseline; end of the treatment (10 days) ; wash-out (4 weeks)
Symptomatology
Change from baseline of vulvovaginal erythema/edema, vulvar discomfort, burning, and itching
Baseline; end of the treatment (10 days) ; wash-out (4 weeks)
Secondary Outcomes (1)
Wellbeing
Baseline; end of the treatment (10 days) ; wash-out (4 weeks)
Study Arms (2)
Probiotic
Assumption of commercially available supplements containing probiotics
Control
No assumption of supplements containing probiotics
Interventions
Eligibility Criteria
healthy volunteers with vaginal microbiota imbalance
You may qualify if:
- Age between 18 and 45 years;
- Presence of at least one vaginal sign or symptom (leucorrhoea, burning, itching, and subjective vaginal discomfort);
- Presence of at least 3 Amsel criteria;
- Nugent score ≥ 7;
- lactobacillary grade ≥ 2 (LBG) (according to Donders classification);
- presence of blastospores and/or pseudohyphae evaluated by fresh mount microscopy
You may not qualify if:
- Age \< 18 years;
- Nugent score \< 7;
- presence of sexually transmitted disease due to Chlamydia, Neisseria gonorrhoeae, or Trichomonas vaginalis as well as specific cervico-vaginitis or severe vulvovaginal symptoms related to acute candidiasis;
- Clinically apparent herpes simplex infection;
- Human papillomavirus or human immunodeficiency virus infections;
- Use of antibiotic, antifungal, probiotic, or immunosuppressive drugs during the past four weeks;
- Use of vaginal contraceptives;
- Pregnancy or breastfeeding, chronic diseases, neoplastic disease, diabetes, genital tract bleeding)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universita degli Studi di Catanialead
- ProBioEtnacollaborator
Study Sites (1)
University of Catania
Catania, 95123, Italy
Biospecimen
vaginal discharge
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Antonio Cianci, Prof
University of Catania
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
March 21, 2023
First Posted
April 18, 2023
Study Start
February 1, 2022
Primary Completion
May 29, 2022
Study Completion
October 30, 2022
Last Updated
April 18, 2023
Record last verified: 2023-04